Patent · US Expired

Motoneuronotrophic factor

US7507713B2 · kind B2 · utility

2Cited by
5References
6Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 1, 2004
Grant dateMar 24, 2009
Priority date
Expiry dateSep 3, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/475
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to a novel purified polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO: 4, one of the member of the Motoneuronotrophic Factor family which has shown to have diagnostic and therapeutic applications in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.